Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.

Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.

Liver Int. 2017 Jun;37(6):888-896. doi: 10.1111/liv.13356. Epub 2017 Feb 3.

PMID:
28061012
2.

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma.

Zhu HT, Hasan AM, Liu RB, Zhang ZC, Zhang X, Wang J, Wang HY, Wang F, Shao JY.

Oncotarget. 2016 Jul 19;7(29):45637-45648. doi: 10.18632/oncotarget.10082.

3.

Statin-Based Palliative Therapy for Hepatocellular Carcinoma.

Shao JY, Lee FP, Chang CL, Wu SY.

Medicine (Baltimore). 2015 Oct;94(42):e1801. doi: 10.1097/MD.0000000000001801.

4.

ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.

Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY.

World J Gastroenterol. 2014 Jan 7;20(1):183-92. doi: 10.3748/wjg.v20.i1.183.

5.

Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia.

Shao JY, Gao HY, Li YH, Zhang Y, Lu YY, Zeng YX.

World J Gastroenterol. 2004 Jun 1;10(11):1560-4.

Supplemental Content

Loading ...
Support Center